How a Boulder-based biotech is helping the FDA locate more common versions of biologics

It can be very difficult to manufacture generic versions of biologic drugs. But SomaLogic has a test that can help determine whether a new drug candidate is similar enough to the original drug to be considered a generic.



Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *

Open

15 gadgets that will sell out in 2020

Close